TAYLOR GIBSON: Open Payments
NPI 1760169130 · JAMESTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $90 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Cipher Pharmaceuticals US LLC | 1 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: CAPLYTA, Natroba, The Cologuard Plus Collection Kit, FANAPT, TRELEGY ELLIPTA, REXULTI, LEQVIO, VRAYLAR.
Industry payments across KY — which companies pay providers there.
